ARTICLE | Management Tracks
Recent deals map out AbbVie’s future as Gonzalez hands CEO job to Michael
COO’s rise to top role closely follows deals designed for long-term growth, while pair of immunology drugs help offset Humira’s shortfall
February 20, 2024 10:53 PM UTC
A pair of late 2023 acquisitions have turned out to be Richard Gonzalez’s last major steps ahead of a leadership transition, setting up AbbVie’s longer-term future as it eyes a return to growth next year.
AbbVie Inc. (NYSE:ABBV) said Tuesday it will elevate President and COO Robert Michael to the CEO role on July 1. Gonzalez, currently AbbVie’s chairman, will retain his spot on the board as executive chairman...
BCIQ Company Profiles